Chargement en cours...
Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer
BACKGROUND: Bevacizumab treatment is subject to large interpatient variability in efficacy, which may partly be explained by differences in complex bevacizumab pharmacokinetic characteristics that influence bevacizumab exposure. Exposure–response relationships have been identified for other monoclon...
Enregistré dans:
| Publié dans: | Oncologist |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7543296/ https://ncbi.nlm.nih.gov/pubmed/32272489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0835 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|